The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Comparison of the effects of cognitive therapy and pharmacotherapy on hopelessness and self-concept

Published Online:https://doi.org/10.1176/ajp.139.7.862

The authors examined the effects of cognitive therapy and imipramine on hopelessness and self-concept in 35 unipolar nonpsychotic depressed outpatients who were treated with either modality over approximately 11 weeks. Compared with imipramine, cognitive therapy resulted in significantly greater improvements in hopelessness and more generalized gains in self-concept. Thus, cognitive therapy may offer a particular advantage in reducing hopelessness and improving low self-concept in depression.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.